Influenza
Conditions
Keywords
preventable disease, vaccine, public health, vaccine history, point-of-care
Brief summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Detailed description
This multi-site study will use a pre-post design with a population-based comparison group to investigate the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Interventions
BIOLOGICALVaccine administration by a pharmacist
Administration, number and types, of vaccines by a pharmacist
Identification of unmet vaccination needs and having those needs met
Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs
Sponsors
American Pharmacists Association Foundation
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Individuals eligible to be enrolled in the study include any person at least 18 years of age who is eligible for a comprehensive vaccination history review as determined by the pharmacist.
Exclusion criteria
* n/a
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in vaccination rates for routinely recommended adult vaccinations | 6 months | Change from baseline rates |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of vaccines administered | 6 months | Change from baseline rates |
| Types of vaccines administered | 6 months | Change from baseline rates |
| Number of unmet vaccination needs that were identified and met | 6 months | Measured through study completion |
Countries
United States
Outcome results
None listed